**To the Editor:** *Bartonella henselae* is the causative agent of cat-scratch disease, which is the most common form of human bartonellosis ([@R1]). In immunocompromised patients, e.g., HIV-infected patients, *B. henselae* can give rise to longstanding fever, bacillary angiomatosis, and peliosis hepatitis ([@R2]). Domestic cats are the reservoir for *B. henselae*, and cat fleas transmit the organism between cats ([@R3]). The seroprevalence and culture findings of *Bartonella* spp. in cats have been shown to be low in Sweden ([@R4],[@R5]) compared with warmer areas ([@R6]). Cat-scratch disease is most often spread from cats to humans by scratches, but other forms of transmission, including cat bites, have been suggested ([@R7]).

To determine seroprevalence of antibodies against *B. henselae* in Sweden, we used data from a recently published prospective study of patients with infected cat bites ([@R8]). In addition to the information about bites, information about cat scratches was collected by retrospective review of the patients' medical records. Serum samples were taken during the patient's first visit to a hospital and at a follow-up visit about 2 weeks later. The study was approved by the local ethics committee.

Immunoglobulin G against specific *Bartonella* spp. was detected by the immunofluorescence antibody test ([@R1]). Cell-cultivated antigens were prepared from the following strains: *B. henselae* Houston-1 (ATCC 49882), *B. henselae* Marseille (CIP 104756), *B. henselae* Berlin1 (M. Arvand), *B. henselae* K68 (E. Olsson-Engvall), *B. elizabethae (*ATCC 49927*)*, and *B. grahamii* (ATCC 700132). The cutoff values for a positive immunofluorescence antibody test result were chosen as [\>]{.ul}128 for *B. henselae* and *B. grahamii* and [\>]{.ul}256 for *B. elizabethae*. The titers are expressed as the reciprocal of the end-point dilution. For controls, we also analyzed serum from 117 blood donors with these antigens. The χ^2^ test was used for statistical analysis.

We analyzed antibodies to *Bartonella* spp. in serum from 71 patients (51 women and 20 men), median age 47 years (range 15--85 years). Only 11 patients had fever. Cat scratches were reported for 17 patients. A single serum sample was obtained from 37 of the 71 patients, and an additional convalescent-phase sample was obtained from 34 patients after a median of 16 days (range 6--54 days).

Antibodies against any *B. henselae* strain were found for 24/71 (34%) patients, against *B. elizabethae* for 9/71 (13%), and against *B. grahamii* for 12/71 (17%). A total of 13/71 (18%) patients showed reactivity to *B. henselae* only*.* Antibodies to any *Bartonella* spp. were found for 28/71 (39%) of the patients. As many as 13/24 (54%) serum samples with antibodies against *B. henselae* reacted to antigens of only that species. More patients (19/71; 27%) reacted to the antigen from the cat in Sweden, K68, than to other strains. The least common reactivity found in this study was against the *B. henselae* Marseille strain.

Of the 117 controls, 1 (0.8%) had antibodies against *B. henselae* K68 antigens, 3 (2.6%) against Berlin1, 2 (1.7%) against Marseille, 1 (0.8%) against Houston-1, and 4 (3.4%) against any *Bartonella* spp. The difference between patients and controls was significant (p\<0.001).

Seroconversion was reported for 6 of the 34 patients (18%) from which 2 serum samples were analyzed ([Table](#T1){ref-type="table"}). Among those who seroconverted for *B. henselae,* 1 had fever and only 2 reported having been scratched. Two of the patients who seroconverted were treated with doxycycline, and 1 was treated with ciprofloxacin. In addition, 1 patient with Sjogren disease was initially treated with penicillin, and later a hemangioma-like exanthema developed. Because of severe acne, the patient was treated with doxycycline for 6 months. The other patients who seroconverted were treated with penicillin or amoxicillin.

###### Titers against *Bartonella* spp. antigens in 6 patients who seroconverted

  Patient sex/ age, y   Reciprocal titer   Interval, d   Antigen   High titer to other antigen   
  --------------------- ------------------ ------------- --------- ----------------------------- -------------------
  F/77                  32                 128           6         *B. henselae* Berlin1         *B. henselae* K68
  F/50                  32                 256           17        *B. henselae* Berlin1         0
  M/74                  128                512           19        *B. grahamii*                 *B. henselae* K68
  F/62                  32                 128           44        *B. elizabethae*              *B. henselae* K68
  M/56                  32                 128           15        *B. henselae* Houston-1       *B. grahamii*
  F/23                  32                 128           10        *B. henselae* Berlin1         *B. grahamii*

Seroconversion for *B. henselae* occurred in 4 patients, of which only 2 had reported a scratch. Three of these patients reacted to *B. henselae* Berlin1, and 1 reacted to the Houston-1 strain. Because symptoms did not differ between the patients who did seroconvert and those who did not, these findings could indicate subclinical infection.

The prevalence of immunoglobulin G against *B. henselae* in particular was shown to be much higher than that previously reported in Sweden ([@R9]). Earlier studies used only 2 *B. henselae* antigens (Houston-1 and Marseille) compared with the 4 different *B. henselae* antigens used in the present study. Most reactivity to *B.* *henselae* in the present study was directed against the Swedish isolate K68 (27%); only 0.8% of controls had antibodies against that antigen.

An increased prevalence of antibodies against *B. henselae* after exposure to cats has been reported from Spain ([@R10]). Because seroconversion against *B*. *henselae* occurred in 2 patients who had not been scratched, cat bites may contribute to transmission of *B. henselae*.
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